FDA Inspection
Octapharma Plasma, Inc.Octapharma Plasma, Inc. – FDA Inspection, May 15, 2015
Record Details
This FDA Inspection record concerns Octapharma Plasma, Inc., with an inspection on May 15, 2015, issued by the Center for Biologics Evaluation and Research, covering biologics.
- Company
- Octapharma Plasma, Inc.
- Inspection Date
- May 15, 2015
- Product Type
- Biologics
View Company Profile
ID · 601b689c-0e42-4bff-8809-dd42963d03b8
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 930212
- FDA center
- Biologics
- Project area
- Blood and Blood Products
FDA Citations
2- 21 CFR 630.40(c)Notification w/in 8 weeks
- 21 CFR 606.160(a)(1)Person performing, test results, interpretation
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Octapharma Plasma, Inc.
4| Date | Classification | Office | Project area |
|---|---|---|---|
| July 9, 2025 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| May 3, 2018 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| December 2, 2011 | VAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| September 18, 2009 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
Other documents for Octapharma Plasma, Inc.
- FDA Inspection 1276299 - 2025-07-09
- FDA Inspection 1053668 - 2018-05-03
- FDA Inspection 760964 - 2011-12-02
- FDA Inspection 615510 - 2009-09-18
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.